Skip to main content
Log in

A controlled trial of azathioprine in Crohn's disease

  • Original Articles
  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Abstract

To determine the efficacy of azathioprine in the treatment of Crohn's disease, a 26-week double-blind trial was performed. 20 patients with Crohn's disease, requiring at least 10 mg of prednisone/day over the 3 months prior to entering the study were randomized into placebo (10 patients) and azathioprine (10 patients) treatment groups. Reduction of steroids was the major criterion of success in the trial. There were 7 relapses in the placebo group (5 patients) and 2 relapses in the azathioprine group (2 patients). Complications including fistulae were not affected by the medications. The mean reduction in steroid dosage in the azathioprine group at the end of the trial (−15.5 mg) was greater than in the placebo group (−6.1 mg). These results suggest that azathioprine may permit reduction or discontinuation of steroids without the worsening of symptoms in some patients who appear to require steroids for control of their symptoms. The clinical features of this “AZA-responsive subgroup” remain to be defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brooke BN, Hoffman DC, Swarbrick ET: Azathioprine for Crohn's disease. Lancet 2:612–614, 1969

    PubMed  Google Scholar 

  2. Brooke BN, Javett SL, Davison OW: Further experience with azathioprine for Crohn's disease. Lancet 2:1050–1053, 1973

    PubMed  Google Scholar 

  3. Patterson JF, Horton RA, Schwartz RS: Azathioprine treatment of ulcerative colitis, granulomatous colitis, and regional enteritis. Am J Dig Dis 16:327–332, 1971

    PubMed  Google Scholar 

  4. Drucker WR, Jeejeebhoy KN: Azathioprine: An adjunct to surgical therapy of granulomatous enteritis. Ann Surg 172:618–625, 1970

    PubMed  Google Scholar 

  5. Willoughby JMT, Parveen KJ, Beckett J, Dawson AM: Controlled trial of azathioprine in Crohn's disease. Lancet 2:944–946, 1971

    PubMed  Google Scholar 

  6. Rhodes J, Bainton D, Beck P, Campbell H: Controlled trial of azathioprine in Crohn's disease. Lancet 2:1273–1276, 1971

    PubMed  Google Scholar 

  7. Klein M, Binder HJ, Mitchell M, Aaronson R, Spiro H: Treatment of Crohn's disease with azathioprine: A controlled evaluation. Gastroenterology 66:916–922, 1974

    PubMed  Google Scholar 

  8. Rosman M, Bertino JR: Azathioprine. Ann Intern Med 79:694–700, 1973

    PubMed  Google Scholar 

  9. Rosenberg JL, Wall AJ, Settles RH, Binder HJ, Levin B, Kirsner JB. A controlled trial of azathioprine in the treatment of chronic ulcerative colitis. Gastroenterology 64:793, 1973

    Google Scholar 

  10. Treatment of Crohn's disease (editorial). Lancet 2:695–696, 1971

  11. Walden BK, Robertson MR, Jeremy D: Skin cancer and immunosuppression. Lancet 2:1282–1283, 1971

    PubMed  Google Scholar 

  12. Doll R, Kinlen L: Immunosurveillance and cancer: Epidemiological evidence. Br Med J 4:420–422, 1970

    PubMed  Google Scholar 

  13. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WF: Crohn's disease and cancer. N Engl J Med 289:1099–1103, 1973

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by a grant from the Gastrointestinal Research Foundation of Chicago and the L. Sinton Fund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenberg, J.L., Levin, B., Wall, A.J. et al. A controlled trial of azathioprine in Crohn's disease. Digest Dis Sci 20, 721–726 (1975). https://doi.org/10.1007/BF01070829

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01070829

Keywords

Navigation